Skip to main content
SpringerLink
Log in

The strongest prognostic factors in colorectal carcinoma

Surgicopathologic stage of disease and postoperative fever

  • Published:
Diseases of the Colon & Rectum

Abstract

Of 227 patients with stage B or C colorectal carcinoma operated for “cure,” 132 had a febrile postoperative course. Of the latter, five patients (3.7 per cent) died of sepsis. The five-year actuarial recurrence rate for 227 patients was 53 per cent. When the patients were divided into groups according to stage of disease and postoperative fever, the following was found:

Eighty-one low stage patients (B1+B2) had a 34 per cent five-year actuarial recurrence rate, and 146 high-stage patients (B3+C1+C2)—a 71 per cent rate (P<0.0005).

Fever occurred postoperatively in 46 per cent of low-stage patients and in 65 per cent of high-stage patients (P=0.004). In low-stage patients, the five-year actuarial recurrence rate was 3 per cent in the group with an afebrile postoperative course, and 66 per cent in that with fever (P<0.0005). Similarly, in high-stage patients, the recurrence rate was 24 and 93 per cent, respectively in the group with afebrile and febrile postoperative courses (P≪0.0005).

Preoperative plasma CEA levels seemed to have no bearing upon prognosis, unless above 20 ng/ml. Eighty-two per cent of patients who had serial postoperative plasma CEA measurements and recurrence of cancer had increasing CEA levels.

Thus, postoperative fever lasting two or more days was the most unfavorable prognostic factor, highly significant statistically, whereas stage of disease ranked only second in isolating better prognoses among operated patients from those at higher risks of recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139:846–52.

    Article  PubMed  CAS  Google Scholar 

  2. Roseman DL, Straus AK. Staging of carcinoma of the colon and rectum. Surg Gynecol Obstet 1980;151:93–5.

    PubMed  CAS  Google Scholar 

  3. Newland RC, Chapuis PH, Pheils MT, MacPherson JG. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer 1981; 47:1424–9.

    Article  PubMed  CAS  Google Scholar 

  4. de Mascarel A, Coindre JM, de Mascarel I, Trojani M, Maree D, Hoerni B. The prognostic significance of specific histologic features of carcinoma of the colon and rectum. Surg Gynecol Obstet 1981;153:511–4.

    PubMed  Google Scholar 

  5. Nowacki M, Szawłowski A, Kukawski P, Kupść W. Analiza statystyczna czynników rokowniczych wśród radykalnie operowanych chorych na raka odbytnicy. Nowotwory 1980;30:249–53.

    PubMed  CAS  Google Scholar 

  6. Polissar L, Sim D, Phil M, Francis A. Survival of colorectal cancer patients in relation to duration of symptoms and other prognostic factors. Dis Colon Rectum 1981;24:364–9.

    PubMed  CAS  Google Scholar 

  7. Phil E, Hughes ESR, Mcdermott FT, Milne BJ, Korner JMN, Price AB. I. Carcinoma of the rectum and rectosigmoid: cancer specific long-term survival. A series of 1061 cases treated by one surgeon. Cancer 1980;45:2902–7.

    Article  Google Scholar 

  8. van Heerden JA, Beart RW Jr. Carcinoma of the colon and rectum complicating chronic ulcerative colitis. Dis Colon Rectum 1980;23:155–9.

    PubMed  Google Scholar 

  9. Baum ML, Anish DS, Chalmers TC, Sacks HS, Smith H Jr, Fagerstrom RM. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of notreatment controls. N Engl J Med 1981;105:795–9.

    Article  Google Scholar 

  10. Dionigi R, Dominioni L, Campani M. Infections in cancer patients. Surg Clin North Am 1980;60:145–59.

    PubMed  CAS  Google Scholar 

  11. Liechty RD, Vanourny SE, Ziffren SE. Intraperitoneal infection and cancer of the colon and rectum. Arch Surg 1968;96:599–603.

    PubMed  CAS  Google Scholar 

  12. Müller W, Regazzoni P. Verbessert ein lokaler postoperativer Infekt die Prognose beim Kolonkarzinom. Helv Chir Acta 1975;54:205–8.

    Google Scholar 

  13. Hafström L, Holmin T. Relationship between postoperative temperature and survival in patients resected for colorectal cancer. Am J Surg 1978;135:213–4.

    Article  PubMed  Google Scholar 

  14. Nauts HC. The beneficial effects of bacterial infections on host resistance to cancer: end results in 449 cases. 2nd ed. NY Cancer Res Inst Monogr 8, 1980.

  15. Laskowski J. Podstawy mianownictwa i klasyfikacji raków z punktu widzenia morfologii. Klasyfikacja. Nowotwory 1932; 7:119–27.

    Google Scholar 

  16. Ackerman LV, del Regato JA. Cancer: diagnosis, treatment and prognosis. 2nd ed. London: H Kimpton, 1954.

    Google Scholar 

  17. Nowacki M, Szawłowski A, Kukawaski P, Mikiewicz B. Rola antybiotyków w przygotowaniu przedoperacyjnych chorychna raka jelita grubego. Pol Przegl Chir 1980;52:311–5.

    PubMed  CAS  Google Scholar 

  18. Szymendera JJ, Nowacki MP, Szawłowski AW, Kamińska JA. Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma. Dis Colon Rectum 1982;25:46–52.

    Article  PubMed  CAS  Google Scholar 

  19. Kaplan ML, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457–81.

    Article  Google Scholar 

  20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from restrospective studies of disease. J Natl Cancer Inst 1959;22: 719–48.

    PubMed  CAS  Google Scholar 

  21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163–70.

    PubMed  CAS  Google Scholar 

  22. Patel SC, Tovee EB, Langer B. Twenty-five years of experience with radical surgical treatment of carcinoma of the extraperitoneal rectum. Surgery 1977;82:460–5.

    PubMed  CAS  Google Scholar 

  23. Faraci R: Rectal cancer: In: Eiseman B, ed. Prognosis of surgical disease. Philadelphia: WB Saunders, 1980:298–301.

    Google Scholar 

  24. DerHagopian RP, Sugarbaker EV, Ketcham A. Inflammatory oncotaxis. JAMA 1978;240:374–5.

    Article  PubMed  CAS  Google Scholar 

  25. Shine T, Wallack MK. Inflammatory oncotaxis after testing the skin of the cancer patient. Cancer 1981;47:1325–8.

    Article  PubMed  CAS  Google Scholar 

  26. Gastpar H. Metastasis prophylaxis by platelet aggregation inhibitors. In: Grundmann E, ed. Metastatic tumor growth. New York: G. Fischer Verlag, 1980:321–31.

    Google Scholar 

  27. Donati MB, Semeraro N, Poggi A: Some interactions between cancer cells and components of the hemostatic system. In: Grundmann E, ed. Metastatic tumor growth. New York: G. Fischer Verlag, 1980;101–6.

    Google Scholar 

  28. Lewis RT, Allan CM, Goodall RG, et al. Preventing anaerobic infection in surgery of the colon. Can J Surg 1981;24:139–42.

    PubMed  CAS  Google Scholar 

  29. Nichols RL. The role of antibiotics in prevention and treatment of wound sepsis (symp). Dis Colon Rectum 1982;25:7–10.

    Google Scholar 

  30. Bergman B, Holm SE, Holmlund D, Kaijser B. Serum antibodies againstEscherichia coli andProteus mirabilis after different types of operations. Acta Chir Scand 1981;147:93–7.

    PubMed  CAS  Google Scholar 

  31. Kearney R, Harrop P. Potentiation of tumor growth by endotoxin in serum from syngeneic tumor-bearing mice. Br J Cancer 1980;42:559–67.

    PubMed  CAS  Google Scholar 

  32. Grassi GG, Pozzi E. Effect of rifampicin on delayed-hypersensitivity reactions. J Infect Dis 1972;126:542–4.

    PubMed  CAS  Google Scholar 

  33. DeMert GJ, Sohnle PG. Effect of chloramphenicol onin vitro function of lymphocytes. J Infect Dis 1979;139:220–4.

    Google Scholar 

  34. Thong YH, Ferrante A. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 1979;35:443–6.

    PubMed  CAS  Google Scholar 

  35. Thong YH, Ferrante A. Miconazole prolongs murine skin graft survival. Clin Exp Immunol 1979;35:10–2.

    PubMed  CAS  Google Scholar 

  36. Skopinska-Rozewska E, Nowaczyk M, Lao M, Gorski AJ. The effect of ampicillin on the expression of Fc-IgG receptors on human peripheral blood lymphocytes. Biomedicine 1981; 35:41–2.

    PubMed  CAS  Google Scholar 

  37. Lundy J. Editorial: the biologic dual effects of anesthesia and surgical treatment in the patient with cancer. Surg Gynecol Obstet 1979;149:245.

    PubMed  CAS  Google Scholar 

  38. Nimberg RB, Glasgow AH, Menzoian JO, et al. Isolation of an immunosuppressive peptide fraction from the serum of cancer patients. Cancer Res 1975;35:1489–93.

    PubMed  CAS  Google Scholar 

  39. Girmann G, Pees H, Schwartze G, Schauerlen PG. Immunosuppression by micromolecular fibrinogen degradation products in cancer. Nature 1976;259:399–401.

    Article  PubMed  CAS  Google Scholar 

  40. Adams GE. Prospects and problems with hypoxic cell radiation sensitizers. In: Breccia A, Rimondi C, Adams GE, eds. Radiosensitizers of hypoxic cells. Amsterdam: Elsevier/North-Holland Biomedical Press, 1979:13–29.

    Google Scholar 

  41. Sablińska B. Znaczenie rokownicze stanów goraczkowych w przebiegu leczenia chorych na raka szyjki macicy. Gin Pol 1977;48:57–64.

    Google Scholar 

  42. Wanebo HJ. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery 1981; 89:290–5.

    PubMed  CAS  Google Scholar 

  43. Goldenberg DM. Immunobiology and biochemical markers of gastrointestinal cancer. In: Stroehlein JR, Romsdahl MM, eds. Gastrointestinal cancer. New York, Raven Press, 1981:65–81.

    Google Scholar 

  44. Goldenberg DM, Neville AM, Carter AC, et al. CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. J Cancer Res Clin Oncol 1981;101:239–42.

    Article  PubMed  CAS  Google Scholar 

  45. Blake KE, Dalbow MH, Concannon JP, et al. Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel. Dis Colon Rectum 1982;25:24–32.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Oncological Surgery and Nuclear Medicine, Maria Skłodowska-Curie Memorial Institute of Oncology, Warsaw, Poland

    Marek P. Nowacki M.D. &  Janusz J. Szymendera M.D.

Authors
  1. Marek P. Nowacki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janusz J. Szymendera M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by grants PR-6/0209 and PR-6/0301 awarded by the Polish National Cancer Program. Also aided by the National Cancer Institute, NIH, DHEW, under the US-Poland Cancer Program.

About this article

Cite this article

Nowacki, M.P., Szymendera, J.J. The strongest prognostic factors in colorectal carcinoma. Dis Colon Rectum 26, 263–268 (1983). https://doi.org/10.1007/BF02562495

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02562495

Key words

Search

Navigation